Liu, Yubin http://orcid.org/0000-0002-5531-6972
Wang, Ziyi
Zhuang, Xinyu
Zhang, Shengnan
Chen, Zhicheng
Zou, Yan
Sheng, Jie
Li, Tianpeng
Tai, Wanbo
Yu, Jinfang
Wang, Yanqun
Zhang, Zhaoyong
Chen, Yunfeng http://orcid.org/0000-0002-5185-4781
Tong, Liangqin http://orcid.org/0000-0002-2717-919X
Yu, Xi http://orcid.org/0000-0002-7724-8317
Wu, Linjuan
Chen, Dong
Zhang, Renli http://orcid.org/0000-0001-5037-1035
Jin, Ningyi
Shen, Weijun http://orcid.org/0000-0001-8388-729X
Zhao, Jincun http://orcid.org/0000-0003-2515-5589
Tian, Mingyao http://orcid.org/0000-0003-0360-3635
Wang, Xinquan http://orcid.org/0000-0003-3136-8070
Cheng, Gong http://orcid.org/0000-0001-7447-5488
Article History
Received: 7 October 2022
Accepted: 30 March 2023
First Online: 17 April 2023
Competing interests
: Patent applications have been filed that cover some of the antibodies presented here. G.C., Y.L., W.T., Y.Z., J.S., and Y.C. are inventors. The other authors declare no competing interests.